Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global cytokine market reached a value of US$ 76.67 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 121.25 Billion by 2027, exhibiting a CAGR of 7.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. 

A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.

Cytokine Market Trends:

The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality. Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth. Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cytokine market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on cytokine type, therapeutic application and end user.

Breakup by Cytokine Type:

  • Tumor Necrosis Factor-TNF
  • Interleukins-Il
  • Interferons-IFN
  • Epidermal Growth Factor-EGF
  • Others
     

Breakup by Therapeutic Application:

  • Cancer
  • Asthma and Airway Inflammation
  • Arthritis
  • Others
     

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic and Research Institutes
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Cytokine Type, Therapeutic Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global cytokine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cytokine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cytokine type?
  • What is the breakup of the market based on the therapeutic application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cytokine market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Cytokine Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Cytokine Type
    6.1    Tumor Necrosis Factor-TNF
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Interleukins-Il
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Interferons-IFN
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Epidermal Growth Factor-EGF
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Therapeutic Application
    7.1    Cancer
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Asthma and Airway Inflammation
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Arthritis
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by End User
    8.1    Pharmaceutical and Biotechnology Companies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Contract Research Organizations
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Academic and Research Institutes
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AbbVie Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Abcam plc
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Amgen Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Applied Biological Materials Inc. (abm)
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Bio-Techne Corporation
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
        14.3.6    F. Hoffmann-La Roche AG
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
        14.3.7    GenScript Biotech Corporation
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Randox Laboratories Ltd.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Thermo Fisher Scientific Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    UCB S.A.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials

List of Figures

Figure 1: Global: Cytokine Market: Major Drivers and Challenges
Figure 2: Global: Cytokine Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cytokine Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Cytokine Market: Breakup by Cytokine Type (in %), 2021
Figure 5: Global: Cytokine Market: Breakup by Therapeutic Application (in %), 2021
Figure 6: Global: Cytokine Market: Breakup by End User (in %), 2021
Figure 7: Global: Cytokine Market: Breakup by Region (in %), 2021
Figure 8: Global: Cytokine (Tumor Necrosis Factor-TNF) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Cytokine (Tumor Necrosis Factor-TNF) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Cytokine (Interleukins-Il) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Cytokine (Interleukins-Il) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Cytokine (Interferons-IFN) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Cytokine (Interferons-IFN) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Cytokine (Epidermal Growth Factor-EGF) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Cytokine (Epidermal Growth Factor-EGF) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Cytokine (Other Cytokine Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Cytokine (Other Cytokine Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Cytokine (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Cytokine (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Cytokine (Asthma and Airway Inflammation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Cytokine (Asthma and Airway Inflammation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Cytokine (Arthritis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Cytokine (Arthritis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Cytokine (Other Therapeutic Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Cytokine (Other Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Cytokine (Contract Research Organizations) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Cytokine (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Cytokine (Academic and Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Cytokine (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: North America: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: North America: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: United States: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: United States: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Canada: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Canada: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Asia-Pacific: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Asia-Pacific: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: China: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: China: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Japan: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Japan: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: India: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: India: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: South Korea: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: South Korea: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Australia: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Australia: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Indonesia: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Indonesia: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Others: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Europe: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Europe: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Germany: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Germany: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: France: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: France: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: United Kingdom: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: United Kingdom: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Italy: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Italy: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Spain: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Spain: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Russia: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Russia: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Latin America: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Latin America: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Brazil: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Brazil: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Mexico: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Mexico: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Middle East and Africa: Cytokine Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Middle East and Africa: Cytokine Market: Breakup by Country (in %), 2021
Figure 80: Middle East and Africa: Cytokine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Global: Cytokine Industry: SWOT Analysis
Figure 82: Global: Cytokine Industry: Value Chain Analysis
Figure 83: Global: Cytokine Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cytokine Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cytokine Market Forecast: Breakup by Cytokine Type (in Million US$), 2022-2027
Table 3: Global: Cytokine Market Forecast: Breakup by Therapeutic Application (in Million US$), 2022-2027
Table 4: Global: Cytokine Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Cytokine Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Cytokine Market: Competitive Structure
Table 7: Global: Cytokine Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links